ALDESLEUKIN for Neoplasm: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 23 adverse event reports in the FDA FAERS database where ALDESLEUKIN was used for Neoplasm.
Most Reported Side Effects for ALDESLEUKIN
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Pyrexia | 112 | 13.5% | 10 | 34 |
| Off label use | 105 | 12.6% | 4 | 27 |
| Pain | 76 | 9.2% | 1 | 16 |
| Hypotension | 62 | 7.5% | 18 | 37 |
| Drug ineffective | 53 | 6.4% | 3 | 19 |
| Thrombocytopenia | 52 | 6.3% | 14 | 29 |
| Hypoxia | 47 | 5.7% | 17 | 32 |
| Fatigue | 46 | 5.5% | 7 | 16 |
| Chills | 45 | 5.4% | 6 | 20 |
| Acute kidney injury | 41 | 4.9% | 12 | 36 |
| Febrile neutropenia | 41 | 4.9% | 4 | 15 |
| Cardiotoxicity | 40 | 4.8% | 2 | 3 |
| Nausea | 38 | 4.6% | 9 | 15 |
| Pancytopenia | 38 | 4.6% | 6 | 29 |
| Anaemia | 35 | 4.2% | 3 | 14 |
Other Indications for ALDESLEUKIN
Neuroblastoma (146)
Metastatic malignant melanoma (137)
Product used for unknown indication (115)
Malignant melanoma (37)
Acute myeloid leukaemia (21)
Graft versus host disease (21)
Non-small cell lung cancer (20)
Renal cell carcinoma (18)
Metastatic renal cell carcinoma (17)
Interleukin therapy (16)
Other Drugs Used for Neoplasm
BEVACIZUMAB (502)
ATEZOLIZUMAB (404)
CYCLOPHOSPHAMIDE (385)
CARBOPLATIN (283)
PACLITAXEL (267)
NIVOLUMAB (219)
OXALIPLATIN (185)
PEMBROLIZUMAB (173)
LENALIDOMIDE (171)
DOXORUBICIN (150)